Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Doubly-Labeled Water.
- Who it may be relevant to
- Registry conditions: Movement Disorders, Energy Metabolism. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to validate previously developed physical function-clustered specific machine-learned accelerometer algorithms to estimate total daily energy expenditure (TDEE) in individuals with general movement and functional limitations.
Detailed description
Current algorithms for examining accelerometer data were developed primarily using data from individuals without movement limitations or impairments. As such, the current available analytic algorithms are inadequate for use with individuals with limitations and impairments to estimate total daily energy expenditure (TDEE). The creation of a new algorithm that can accurately assess TDEE in individuals with movement limitations will be beneficial for future research examining physical activity interventions targeted to these individuals. This study will serve to validate a new algorithm that was developed specifically to analyze accelerometer data for individuals with movement limitations, and gauge the accuracy of the new algorithm's ability to accurately assess TDEE against one of the gold standards of TDEE measurement, the doubly labelled water technique.
Approximately 125 adults, 50 from Colorado, and 75 from Wisconsin, will participate in this study. Participants will complete three study visits. During the first visit, physical function will be assessed during a series of tests, and a dual-energy X-ray absorptiometry (DXA) scan will be performed to obtain information on body composition. During the second visit, the participant will complete a resting metabolic rate (RMR) examination, will consume a dose of doubly labeled water, and will provide urine and saliva samples. At the end of the second visit, participants will be given a set of accelerometers to wear for 8-10 days, and will be asked to complete a wear log for documentation. After 8-10 days have passed, during the final visit, participants will provide additional urine samples and return the accelerometers.
The hypothesis being tested is that physical function-clustered specific machine-learned accelerometer algorithms will produce more accurate and precise estimations of TDEE during free-living compared with healthy population derived accelerometer algorithms applied to diverse populations.
Interventions
- Other Doubly-Labeled Water
All eligible participants will receive a dose of doubly-labeled water.
Primary outcome measures
- Accuracy of accelerometer derived estimations of total daily energy expenditure (TDEE, kcals/day). [Time frame: 8-10 days monitoring]
- Precision of accelerometer derived estimations of total daily energy expenditure (TDEE, kcals/day). [Time frame: 8-10 days monitoring]
- Total Daily Energy Expenditure (TDEE) (via DLW) [Time frame: pre-dose; 4 hours and 5 hours post-dose, and 8-10 days post-dose]
Secondary outcome measures (6)
- Resting Metabolic Rate (kcals/day) [Time frame: pre-dose]
- Fat free body mass (g) [Time frame: 7-14 days before dose]
- Modified Physical Performance Test (MPPT) [Time frame: 7-14 days before dose]
- Maximum hand grip strength [Time frame: 7-14 days before dose]
- Gait speed [Time frame: 7-14 days before dose]
- Temporospatial gait analysis [Time frame: 7-14 days before dose]
Eligibility criteria
Inclusion criteria
- must be 18+ years of age
- be able to ambulate on own, unassisted, on a regular basis
- speak and read English
- must have access to a working smart phone and a computer with internet access
Exclusion criteria
- wheelchair reliant
- assistive walking device reliant (cannot walk for at least 50 feet without an assistive device)
- diagnosed uncontrolled hypertension (above 160/100 mgHg)
- diagnosed cognitive impairment or inability to follow study procedures such as Alzheimer's disease or dementia
- cannot take metabolic altering medications
- cannot be pregnant
- cannot be breastfeeding
- cannot use supplemental oxygen
- cannot completed required study activities for any reason
- cannot have a resting heart rate > 100 bpm or a resting blood pressure > 160 mgHg during Visit 1
- cannot weigh more than 450 lbs
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-only
Study locations
United States · 1 center
- University of Wisconsin-Milwaukee — Milwaukee
Identifiers
NCT: NCT05736302 · 21.061 · R01CA215318